| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2021-12-10 | Antal James Director | Sale | -30,000 | -22.92%100,875 | $7.82 | $234,600 | View SEC filing | |
| 2020-08-28 | Antal James Director | Sale | -30,000 | -20.57%115,875 | $7.10 | $213,000 | View SEC filing | |
| 2019-12-10 | SAVAS PAUL G Director | Purchase | +20,000 | +7.33%292,847 | $4.37 | $87,400 | View SEC filing | |
| 2019-12-10 | Kane Julie Director | Purchase | +2,500 | +100.00%2,500 | $4.39 | $10,975 | View SEC filing | |
| 2019-12-10 | Gomez Phillip Louis III Chief Executive Officer | Purchase | +10,000 | +2.15%475,782 | $4.42 | $44,200 | View SEC filing | |
| 2019-12-10 | Luckshire Daniel J Executive VP & CFO | Purchase | +5,000 | +2.27%224,943 | $4.39 | $21,950 | View SEC filing | |
| 2019-08-26 | SAVAS PAUL G Director | Purchase | +10,000 | +3.80%272,847 | $4.95 | $49,500 | View SEC filing | |
| 2019-08-12 | SAVAS PAUL G Director | Purchase | +10,000 | +3.95%262,847 | $5.08 | $50,800 | View SEC filing | |
| 2019-07-02 | BAYER MICHAEL J Director | Mixed | -1,460 | -1.09%132,244 | $3.50 | $92,550 | View SEC filing | |
| 2019-07-02 | BAYER MICHAEL J Director | Purchase | +8,284 | +145.95%13,960 | $3.59 | $29,740 | View SEC filing | |
| 2019-06-07 | Antal James Director | Sale | -30,000 | -18.65%130,875 | $5.70 | $171,000 | View SEC filing | |
| 2019-06-07 | Hruby Dennis E VP & Chief Scientific Officer | Sale | -50,000 | -25.32%147,465 | $5.61 | $280,530 | View SEC filing | |
| 2018-11-19 | SAVAS PAUL G Director | Purchase | +5,000 | +2.15%237,847 | $5.58 | $27,900 | View SEC filing | |
| 2018-11-13 | Hruby Dennis E VP & Chief Scientific Officer | Sale | -50,000 | -20.20%197,465 | $5.17 | $258,263 | View SEC filing | |
| 2018-11-13 | Gomez Phillip Louis III Chief Executive Officer | Purchase | +15,000 | +100.00%15,000 | $5.20 | $78,000 | View SEC filing | |
| 2018-11-13 | SAVAS PAUL G Director | Purchase | +10,000 | +4.49%232,847 | $5.01 | $50,100 | View SEC filing | |
| 2015-09-24 | ROSE ERIC A MD Chief Executive Officer | Sale | -20,000 | -3.32%582,897 | $1.21 | $24,200 | View SEC filing | |
| 2015-09-03 | ROSE ERIC A MD Chief Executive Officer | Sale | -20,000 | -3.82%502,897 | $1.32 | $26,400 | View SEC filing | |
| 2015-06-24 | ROSE ERIC A MD Chief Executive Officer | Sale | -25,000 | -5.02%472,897 | $1.43 | $35,786 | View SEC filing | |
| 2015-06-17 | Luckshire Daniel J Executive VP & CFO | Sale | -7,500 | -14.12%45,602 | $1.54 | $11,550 | View SEC filing | |
| 2015-06-05 | Hruby Dennis E VP & Chief Scientific Officer | Sale | -40,000 | -45.91%47,124 | $1.62 | $64,765 | View SEC filing | |
| 2015-06-04 | ROSE ERIC A MD Chief Executive Officer | Sale | -25,000 | -5.29%447,897 | $1.67 | $41,641 | View SEC filing | |
| 2014-11-10 | MacAndrews & Forbes LLC Director, 10% Owner | Purchase | +199,727 | +1.50%13,509,722 | $1.50 | $299,120 | View SEC filing | |
| 2014-09-29 | SLOVIN BRUCE Director | Sale | -25,000 | -20.83%95,000 | $1.35 | $33,750 | View SEC filing | |
| 2014-09-25 | MacAndrews & Forbes LLC Director, 10% Owner | Purchase | +204,157 | +1.56%13,309,995 | $1.34 | $272,743 | View SEC filing |
1-25 of 79
